购物车
- 全部删除
- 您的购物车当前为空
PCSK9-IN-31 (Compound WX002) 作为一种有效的口服PCSK9抑制剂,能显著降低高胆固醇喂养大鼠模型中的低密度脂蛋白胆固醇 (LDL-C) 和总胆固醇 (TC) 水平.
PCSK9-IN-31 (Compound WX002) 作为一种有效的口服PCSK9抑制剂,能显著降低高胆固醇喂养大鼠模型中的低密度脂蛋白胆固醇 (LDL-C) 和总胆固醇 (TC) 水平.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | PCSK9-IN-31 (Compound WX002) is an orally effective PCSK9 inhibitor. It has been shown to reduce levels of low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in a high cholesterol-fed rat model. |
分子量 | 406.48 |
分子式 | C23H26N4O3 |
CAS No. | 2247649-76-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.